Table 1 Demographics and preoperative characteristics
Demographics % (N) or mean/median (SD/IR) | Ependymoma (13) | Subependymoma (21) | Central Neurocytoma (10) | GEC (1) | Total (45) |
|---|---|---|---|---|---|
Age | 54.7 (±20.2) | 58 (±12) | 41.7 (±15.2) | 18 | 52.5 (±17.1) |
Sex | M 46.2% (6) | M 61.9% (13) | M 60.0% (6) | M 0 | M 25 (55.6%) |
F 53.8% (7) | F 38.1% (8) | F 40.0% (4) | F 1 | F 20 (44.4%) | |
Clinical presentation | |||||
 Pre-operative KPSS | 90% (IR 80–90) | 90% (IR 90–90) | 90 (IR 90–90) | 90 | 90 (IR90–90) |
 Asymptomatic | 30.8% (4) | 9.6% (2) | 10.0% (1) | 0 | 15.6% (7) |
 Recurrence | 15.4% (2) | 0 | 10.0% (1) |  | 6.6% (3) |
 Cranial nerve deficits | III 7.7% (1) V 7.7% (1) IX 15.4% (2) XII 7.7% (1) | 0 | 0 | 0 | 11.1% (5) |
 Diplopia | 7.7% (1) | 4.8% (1) | 10.0% (1) | 0 | 6.7% (3) |
 Cephalgia | 38.5% (5) | 42.9% (9) | 80.0% (8) | 0 | 48.9% (22) |
 Vertigo/Nausea | 0 | 47.6% (10) | 50.0% (5) | 0 | 33.3% (15) |
 Hydrocephalus / Concentration disorder | 23.1% (3) | 23.8% (5) | 20.0% (2) | 100% (1) | 24.4% (11) |
 Disequilibrium / Ataxia / Cerebellar symptoms | 30.8% (4) | 9.5% (2) | 0 | 0 | 13.3% (6) |
 Dysphagia / Dysarthria | 7.7% (1) | 0 | 0 | 0 | 2.2% (1) |
 Hemihypesthesia | 7.7% (1) | 0 | 0 | 0 | 2.2% (1) |